Interpreting Biomarker Discordance in Inflammatory Bowel Disease: Beyond Fecal Calprotectin and C-Reactive Protein.

Stelara (ustekinumab) - J&J

Entyvio (vedolizumab) - Takeda

http://www.ncbi.nlm.nih.gov/pubmed/42792627

Dinko Martinovic; Josko Bozic; Lovre Martinovic; Marino Vilovic; Marko Kumric; Roko Santic

Sep 27, 2026